Commonwealth Bank of Australia’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Commonwealth Bank of Australia’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-727	Closed	-$84K	–	855
2015 Q2	$84K	Sell	727 -638	-47%	-$67K	﹤0.01%	626
2015 Q1	$130K	Buy	+1,365	New	+$102K	﹤0.01%	593

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Commonwealth Bank of Australia's CBPO Position: Q3 2015 in Review

Commonwealth Bank of Australia sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2015, closing a stake of 727 shares — an estimated $84K sold.

Commonwealth Bank of Australia first reported a position in CBPO in Q1 2015 and held it in 2 quarters. The position peaked at $130K in Q1 2015. 106 funds tracked by Wall St. Rank hold CBPO as of Q3 2015.

Commonwealth Bank of Australia reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
Commonwealth Bank of Australia sold 727 China Biologic Products Holdings, Inc. shares in Q3 2015, an estimated $84K.
Commonwealth Bank of Australia first reported a position in China Biologic Products Holdings, Inc. in Q1 2015 and held it in 2 quarters.
Commonwealth Bank of Australia's China Biologic Products Holdings, Inc. position peaked at $130K in Q1 2015.
106 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2015.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2015, filed 12 Nov 2015.